Table 1.
Baseline Participant Sociodemographic and Clinical Characteristics
| Group | ||||
|---|---|---|---|---|
| Variable | Intervention (n=123) | Usual Care (n=126) | ||
| Sociodemographic | ||||
| Age, mean (SD), y | 49.8 | (8.7) | 49.8 | (10.5) |
| Male sex | 120 | (97.6) | 122 | (96.8) |
| African American race | 78 | (63.4) | 77 | (61.6) |
| Single/never married | 103 | (83.7) | 98 | (77.8) |
| High school graduate or higher | 118 | (95.9) | 113 | (89.7) |
| Annual income ≥ $20,000 | 60 | (50.8) | 52 | (42.6) |
| Clinical | ||||
| SF-12V PCS score, mean (SD) | 41.5 | (12.5) | 39.5 | (11.6) |
| SF-12V MCS score, mean (SD) | 34.3 | (10.5) | 35.1 | (11.0) |
| SCL-20 score, mean (SD) | 1.8 | (0.6) | 1.9 | (0.7) |
| QWB-SA score, mean (SD)** | 0.49 | (0.1) | 0.44 | (0.1) |
| Physical health comorbidity score, mean (SD)* | 3.2 | (2.3) | 3.8 | (2.3) |
| PHQ-9, mean (SD) | 15.7 | (4.2) | 16 | (4.7) |
| Major depression | 92 | (74.8) | 98 | (77.8) |
| Panic disorder | 10 | (8.1) | 18 | (14.3) |
| Generalized anxiety disorder | 74 | (60.2) | 76 | (60.3) |
| Posttraumatic stress disorder | 34 | (27.6) | 40 | (31.7) |
| At-risk drinking | 19 | (15.4) | 26 | (20.6) |
| Any inpatient mental health admission | 33 | (26.8) | 32 | (25.4) |
| Any past depression treatment | 98 | (79.7) | 98 | (77.8) |
| Any depression treatment in past 6 mos. | 68 | (55.7) | 67 | (53.2) |
| Depression treatment type | ||||
| Watchful waiting acceptable | 88 | (71.5) | 85 | (67.5) |
| Antidepressant medication acceptable | 88 | (72.1) | 87 | (69.6) |
| Individual counseling acceptable | 108 | (87.8) | 113 | (89.7) |
| Group counseling acceptable | 66 | (53.5) | 76 | (60.3) |
| Bothersome HIV symptoms, mean (SD) | 7.8 | (4.1) | 8 | (4.3) |
| Current anti-HIV prescription | 99 | (80.5) | 99 | (78.6) |
| Skipped anti-HIV medication in past 4 d | 23 | (23.2) | 28 | (28.3) |
| Anti-HIV medication adherence, mean % (SD) | 93.5 | (16.2) | 91.2 | (20.1) |
| Current AD prescription | 75 | (61.0) | 78 | (61.9) |
| Skipped AD in past 4 d | 22 | (29.3) | 20 | (25.6) |
| AD regimen adherence, mean % (SD) | 85.4 | (30.5) | 86.4 | (31.1) |
Abbreviations: AD, antidepressant; HIV, human immunodeficiency virus; MCS, mental component summary; PCS, physical component summary; PHQ-9, 9-item Patient Health Questionnaire; QWB-SA, Quality of Well-Being Self-administered Scale; SCL-20, 20-item Hopkins Symptom Checklist; SF-12V, Medical Outcomes Study Veterans 12-Item Short-Form Health Survey.
Unless otherwise indicated, data are expressed as number (percentage) of participants. Percentages reflect the following missing data: race, 1 usual care participant; annual income, 5 intervention and 4 usual care participants; any depression treatment in the past 6 months, 1 intervention participant; and antidepressant acceptable, 1 intervention and 1 usual care participant.
P .01 for intervention vs usual care.
P .05 for intervention vs usual care.
The PHQ-9 was used as depression screening measure. The SCL-20 was used as the depression outcome measure.
Mental health comorbidity was identified using the Mini International Neuropsychiatric Interview.